Author  
Place of duty  
Title   Àå±â Ç×¾Ï È­Çпä¹ýÀ» À§ÇÑ ¿ÏÀü¸Å¸³ Ç÷°ü Æ÷Æ®ÀÇ ÀÓ»óÆò°¡ ( Clinical Evaluation of a Totally Implantable Venous Access System for Long - term Anticancer Chemotherapy )
Publicationinfo   1991 Jan; 023(02): 424-429.
Key_word   Venous access system, Chemotherapy
Full-Text  
Abstract   Long-term venous access has been a major concern of health care providers for many years, fostering the development of arterial fistulas, external right atrial catheters and in recent years, totally implanted infusion ports. We have investigated infusion ports as a means of vascular access for long-term anti-cancer chemotherapy from May, 1989 to August, 1990. During that period a total of 20 ports have been implanted in patients ranging in age from 43-74 years (mean 61). Placement has been successful in 100% of attemps. The median duration of implant in 13 months abservation period was 8+ months as calculated by Kaplan-Meier survival curve. 8 patients have died of progressive cancer while the infusion pots were kept intact. No local or systemic infections have occurred. Clotting in reservoir was the cause of termination of ports in 2 patients. The rest 10 patients are using ports well with no complications as of the date of this report. The infusion port has been uniformly successful for infusiona1 therapies with chemotherapeutic agents, blood products and other intra- venous solutions, both in the hospital and the outpatient setting. We believe the implantable port provides a useful new option with unique advantages in terms of implantation technique, ease of use and in convenience and cosmetic appeal to patients.
Àú ÀÚ   Á¤ÅÂÁØ(Te June Chung),Á¤¿ø»ó(Won Sang Chung),±è¿µÇÐ(Young Hak Kim)